Indeed, in murine tumor models, success of ICI treatment depends on a ‘display-on/fast-off’ kinetic of IFNβ signaling where fast reduction of ISG expression is associated with responding tumors (Zemek et al, 2022). This evidence concerns the gene IFNB1 and neoplasm.